Saturday, March 6, 2021
Home Latest Pharma-News

Latest Pharma-News

15 Companies received warning letter by U.S. Food and Drug Administration for illegally selling products containing cannabidiol as agency details safety concerns

Nov 25, 2019: 15 Companies received warning letter by U.S. Food and Drug Administration the for illegally selling products containing cannabidiol that...

Oxbryta (voxelotor) approved by U.S. Food and Drug Administration for the treatment of sickle cell disease (SCD)

Nov 25, 2019 Oxbryta (voxelotor)approved by  the U.S. Food and Drug Administration  for the treatment of sickle cell disease (SCD) in adults...

The first oral small molecule targeting splicing Risdiplam approved by US FDA for the treatment of spinal muscular atrophy

Nov 25, 2019: PTC Therapeutics, Inc announced that the United States Food and Drug Administration (FDA) has granted priority review for the...

Vaccitech announces successful recruitment and vaccination for two phase 2 Universal influenza studies FLU009 and FLU010 for the treatment and prevention of cancer...

Nov 25, 2019: Vaccitech Ltd, a clinical-stage T cell immunotherapy company develop the products for the treatment and prevention of  cancer and infectious...

FDA approves new system for the delivery of tympanostomy tubes under local anesthesia to treat ear infection

Nov 25, 2019 :Tusker Medical recievied approval from The U.S. Food and Drug Administration for the delivery of tympanostomy tubes (ear tubes)...

Takeda says cancer drug Alunbrig (brigatinib) results in longer benefit vs crizotinib After Two Years of Follow-Up

Nov 23, 2019: Data updated by Takeda Pharmaceutical from its Phase 3 ALTA-1L trial  evaluating ALUNBRIG versus crizotinib in adults with advanced...

Roche presents pivotal First Phase III cancer immunotherapy Tecentriq in combination with Avastin to show an improvement in liver cancer patients

Nov 22,2019: Roche presents positive results from the Phase III IMbrave150 study evaluating Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment  of...

ViiV Healthcare announces exclusive licensing agreement with NIH to develop investigational bNAb N6LS for treatment & prevention of HIV-1

Nov 21,2019 : ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced...

BioMarin seeks European marketing Authorization for valoctocogene roxaparvovec to treat severe hemophilia A

Nov 21,2019: BioMarin Pharmaceutical Inc. announced that the company submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for...

Amgen Completes Acquisition Of Otezla® (apremilast) for the treatment of moderate-to-severe plaque psoriasis, psoriatic arthritis

Nov. 21, 2019: Amgen announced the successful completion of its acquisition of worldwide rights to Otezla® (apremilast), the only oral, non-biologic treatment for...

Aquestive Therapeutics’ treatment approved by FDA for neurological disorder amyotrophic lateral sclerosis (ALS)

Nov 22, 2019: The U.S. Food and Drug Administration approved Aquestive Therapeutics' treatment for neurological disorder amyotrophic lateral sclerosis (ALS).

AbbVie to present Ibrutinib (IMBRUVICA®) plus venetoclax (VENCLEXTA®/ VENCLYXTO®) , in American Society of Hematology (ASH) Annual Meeting for the treatment of...

Nov 21, 2019 : AbbVie, a research-based global biopharmaceutical company announced that between Dec 7- 10  in American Society of Hematology (ASH) Annual Meeting...

Most Read

FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test

March 05, 2021: "The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the T-Detect COVID Test developed by...

EMA issues advice on Lilly’s bamlanivimab with etesevimab for confirmed COVID-19 in EU

March 5, 2021: "Eli Lilly and Company announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion...

MHRA says modified COVID-19 vaccines for variants to be fast-tracked

March 04, 2021: "Authorised COVID-19 vaccines that are modified in response to new variants will not need a brand new approval or “lengthy” clinical studies,...

Co-WIN Covid-19 vaccine registration prosess

Co-WIN Covid-19 vaccine registration: The registrations for the Covid-19 vaccine registration opened from 9 AM on March 1 till 3 PM every...